Multicenter prospective registration study evaluating diagnostic yield of the 22G Franseen needle in patients undergoing EUS-guided tissue acquisition of pancreatic solid lesions

Multicenter prospective registration study evaluating diagnostic yield of the 22G Franseen needle in patients undergoing EUS-guided tissue acquisition of pancreatic solid lesions - Multicenter prospective registration study evaluating EUS-FNA using the 22G Franseen needle

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000033530

Enrollment

235

Registered

2018-07-30

Start date

2018-07-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic tumors

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Patients who are over 20 years old. 2)Patients with pancreatic solid tumors. 3)Patients who need histopathological diagnosis for pancreatic neoplasms by EUS-FNB. 4)Patients who provided written informed consent.

Exclusion criteria

Exclusion criteria: 1)Patients who are not applicable to endoscopy and EUS-FNB. 2)Patients who judged as inappropriate by attendant doctor. 3)Patients who rejected participating in this study.

Design outcomes

Primary

Measure	Time frame
Diagnostic accuracy of EUS-FNB using the 22G Franseen needle	—

Countries

Japan

Contacts

Public ContactKazunaga Ishigaki

Tokyo University Department of Gastroenterology

ishigakikazunaga@gmail.com03-3815-5411

Outcome results